Lexeo Therapeutics Common Stock

Lexeo Therapeutics (LXEO) currently reports a common stock of $7K as of March 2026. That compares with $3K in the prior-year period — up 133.3% year over year. Use the charts on this page to explore Lexeo Therapeutics's common stock history and peer comparisons.

Lexeo Therapeutics's common stock increased from $3K to $7K — a 133.3% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lexeo Therapeutics reported $7K in common stock as of March 2026. That compares with $3K in the prior-year period — up 133.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $7K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lexeo Therapeutics, and consider following LXEO for alerts when major investors trade the stock.